MiniMed Group, Inc.

MMED Healthcare Medical Instruments & Supplies

MiniMed Group, Inc.’s revenue for fiscal 2026 (year ended April 2026) was $3.1 billion, up 14.3% from fiscal 2025.

18.23 1.06 −5.50%
Market cap
$5.1B
P/E
0.0×
Fwd P/E
27.8×
Dividend yield
—
F-score
n/a
Altman Z
2.53
Beneish M
−3.09
Dividend safety
n/a

MiniMed Group, Inc. (MMED) Price to free cash flow

Alert me on Price to free cash flow

MiniMed Group, Inc. has no meaningful price to free cash flow: its trailing twelve-month free cash flow is negative. Over the past ten years it has ranged from 0.0× (November 2026) to 0.0× (November 2026) — the current reading is the highest in ten years.

Price to free cash flow, daily

Embed this chart

Annual newest first

Period Price to free cash flow Change
FY2026 0.0× —
FY2025 0.0× —
FY2024 0.0× —

Quarterly newest first

Period Price to free cash flow Change
Jul 2026 0.0× —
Jan 2026 0.0× —
Jul 2025 0.0× —
Jan 2025 0.0× —

Against its own ten years

Low 0.0× High 0.0×
Ten-year median 0.0×
Current reading's percentile 100

Price to free cash flow against peers

Company Price to free cash flow
STVN Stevanato Group S.p.A. compare n/m
PLSE Pulse Biosciences, Inc compare n/m
MMED MiniMed Group, Inc. n/m
NVST Envista Holdings Corporation compare 16.4×
ICUI ICU Medical, Inc. compare 21.2×
MMSI Merit Medical Systems, Inc. compare 23.6×
BLCO Bausch + Lomb Corporation compare 31.4×
TFX Teleflex Incorporated compare 125×
ATRC AtriCure, Inc. compare 129×
Medical Instruments & Supplies industry median 23.5×
Healthcare sector median 21.1×
Market median 14.1×

What Price to free cash flow is

Price to Free Cash Flow Ratio shows how much investors pay for each dollar of cash a company generates after its capital spending.

Stock Price ÷ ((Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM)) ÷ (Shares (Basic, Weighted) (latest quarter)))

The full definition of Price to free cash flow →

More on MMED